Updates 2025 EPS Guidance with $823M IPR&D Expense

finance.yahoo.com/news/abbvie-abbv-updates-2025-eps-153054734.html

In This Article:
AbbVie Inc. (NYSE:ABBV) is one of the 7 most undervalued pot stocks to buy according to analysts. On July 3, the company provided an update to its 2025 earnings guidance to account for a pre-tax acquired in-process research and development (IPR&D) and milestones expense…

This story appeared on finance.yahoo.com, 2025-07-14 15:30:54.
The Entire Business World on a Single Page. Free to Use →